Twin study finds possible connection between depression, hea...( to CHD because it can raise the risk o...)

Twin study finds possible connection between depression, heart disease

to CHD because it can raise the risk of arrhythmias and sudden death," Dr. Vaccarino says.

She adds that the results of the twin study are important not only because they provide an explanation for how depression increases CHD risk in persons without CHD initially, but also because they underscore the clinical significance of minor depression in addition to major depression. "The data suggest that treatment of clinical depression, and perhaps also minor forms of depression, should reduce the risk of CHD via normalization of HRV," Dr. Vaccarino states. "Hopefully, there will be future clinical trials to test this idea in a controlled, randomized fashion. "

'"/>

Contact: Sherry Baker
emoryheartnews@aol.com
404-377-1398
Emory University Health Sciences Center
8-Mar-2004

Page: 1 2
Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:

(Date:5/21/2013)... 2013 Parker Waichman LLP, a national ... injured by defective medical devices, is addressing new research ... on May 15, 2013. The study found that magnetic ... that occur in patients with metal-on-metal hip implants even ... ) , “We’ve known for quite ...

(Date:5/21/2013)... 2013 Artisan Business Group is ... Dealmakers Conference in Long Beach, California on May ... exploring alternative finance through EB-5 immigrant investors program. ... and economic information, and updates to project developers, ... the EB-5 industry. , "Our goal is ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 Arizona ... inventors who want to develop their ideas into ... program. , The university is recruiting participants ... new “formation space” that provides early-stage entrepreneurs with ... AREA48 is open to anyone, ASU is particularly ...

(Date:5/21/2013)... The In View series , a ... channels across the country, announces it has posted a ... producers of the series proudly bring audiences across the ... manufacturing industry, health-related companies, medical facilities and more. The ... in all parts of the United States, Canada and ...

(Date:5/21/2013)... 21, 2013 Global Proving Ground (GPG), ... the largest online retailer of health and fitness supplements, ... sports show, Warrior Island. “We cast the show ... & Twitter, with our unique social networking platform,” states ... elite fighters on an island in the Pacific Ocean, ...

Breaking Medicine News(10 mins):Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3 Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4 Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2 Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2 Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3

[0] Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants [0] Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California [0] ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors [0] In View hosted by Larry King Announces New Videos on its YouTube Channel [0] Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island

(Date:5/21/2013)... N.J. , May 21, 2013 /PRNewswire-iReach/ -- The ... in NJ has attracted the greatest number of ... its President, Mark Alexay . ... plans to attend this year. The show,s still 4 ... different companies. This is a big surprise and ...

(Date:5/21/2013)... BURLINGTON, Mass. , May 21, 2013 ... leading research and advisory firms for pharmaceutical ... of an emerging agent on key efficacy ... disease progression, has the most influence over ... for advanced/metastatic hormone-receptor (HR-) positive, HER2-negative breast ...

(Date:5/21/2013)... 2013 IsoRay, Inc. (AMEX: ISR ), ... into an exclusive international distribution agreement with IASIS Medical ... Greece . IsoRay is a medical ... radioisotope applications for brain cancer, lung cancer, head and ... IASIS Medical is ideally suited to support ...

Breaking Medicine Technology:Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2 Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2 IsoRay Announces A New International Distributor For Greece 2 IsoRay Announces A New International Distributor For Greece 3

[0] Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show [0] Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer [0] IsoRay Announces A New International Distributor For Greece